Characteristic | All patients N (%) | Surgery N (%) | No surgery N (%) | P value |
---|---|---|---|---|
Total patients | 189 | 90 (47.6) | 99 (52.4) | |
Age in years, mean±SD | 65.9±14.5 | 67.5±13.7 | 64.5±15.1 | 0.158 |
Female | 101 (53.4) | 45 (50) | 56 (56.6) | 0.817 |
Type of cancer | ||||
Lower GI | 97 (51.3) | 54 (60) | 43 (43.4) | |
Upper GI | 26 (13.8) | 10 (11.1) | 16 (16.2) | |
Non-viscerala | 29 (15.3) | 12 (13.3) | 17 (17.2) | 0.051 |
Hematological | 11 (5.8) | 7 (7.8) | 4 (4) | |
Othersb | 26 (13.8) | 7 (7.8) | 19 (19.2) | |
New cancer diagnosis | 42 (22.2) | 27 (30) | 15 (15.2) | 0.014 |
Metastatic disease | 94 (49.7) | 35 (38.9) | 59 (59.6) | 0.004 |
Systemic therapyc | 55 (29.1) | 14 (15.6) | 41 (41.4) | <0.001 |
Adjuvant therapyd | 70 (37) | 37 (41.1) | 33 (33.3) | 0.269 |
Radiation therapy | 2 (1.1) | 0 | 2 (2) | - |
Mortality | 105 (55.6) | 48 (53.3) | 57 (57.6) | 0.558 |
30-day mortality | 28 (14.8) | 6 (6.7) | 22 (22.2) | 0.003 |
60-day mortality | 41 (21.7) | 14 (15.6) | 27 (27.3) | 0.051 |